These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17256186)

  • 1. Atypical antipsychotic drugs and Alzheimer's disease.
    Jockers-Scherübl MC; Hellweg R
    N Engl J Med; 2007 Jan; 356(4):416-7; author reply 417-8. PubMed ID: 17256186
    [No Abstract]   [Full Text] [Related]  

  • 2. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
    Förstl H
    Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical antipsychotic drugs and Alzheimer's disease.
    Hussain HM; Hotopf M; Oyebode F
    N Engl J Med; 2007 Jan; 356(4):416; author reply 417-8. PubMed ID: 17251541
    [No Abstract]   [Full Text] [Related]  

  • 4. New Rx for psychoses in Alzheimer's, Parkinson's.
    Targum SD
    Contemp Longterm Care; 2001 Jan; 24(1):39-40. PubMed ID: 11209286
    [No Abstract]   [Full Text] [Related]  

  • 5. Alzheimer's disease--clinical trials and the logic of clinical purpose.
    Karlawish J
    N Engl J Med; 2006 Oct; 355(15):1604-6. PubMed ID: 17035654
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperglycaemia in an 11-year-old girl after quetiapine treatment.
    Emul M; Asik A; Sen T; Gunes C; Demir T
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1568-9. PubMed ID: 19751792
    [No Abstract]   [Full Text] [Related]  

  • 7. Preferences of general practitioners and carers of Alzheimer patients regarding the use of neuroleptics for behavioural disorders in Alzheimer's disease.
    Gonzalez-Moneo MJ; Simó M; Pie M; Rivero D
    Int J Geriatr Psychiatry; 2008 Oct; 23(10):1095-7. PubMed ID: 18613282
    [No Abstract]   [Full Text] [Related]  

  • 8. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
    Paleacu D; Barak Y; Mirecky I; Mazeh D
    Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous quetiapine abuse.
    Hussain MZ; Waheed W; Hussain S
    Am J Psychiatry; 2005 Sep; 162(9):1755-6. PubMed ID: 16135642
    [No Abstract]   [Full Text] [Related]  

  • 10. Weight change in Parkinson and Alzheimer patients taking atypical antipsychotic drugs.
    Sitburana O; Rountree S; Ondo WG
    J Neurol Sci; 2008 Sep; 272(1-2):77-82. PubMed ID: 18556024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid function alterations following quetiapine initiation in a developmentally disabled adolescent.
    Dobbs RL; Brahm NC; Fast G; Brown RC
    Ann Pharmacother; 2004 Sep; 38(9):1541-2. PubMed ID: 15252194
    [No Abstract]   [Full Text] [Related]  

  • 12. Are atypical antipsychotics safe in patients with Alzheimer's disease?
    Jones SS
    Am Fam Physician; 2006 Aug; 74(3):414. PubMed ID: 16913159
    [No Abstract]   [Full Text] [Related]  

  • 13. The art of prescribing: pharmacological management of psychosis in Alzheimer's disease: clinical challenges associated with second-generation antipsychotic medications.
    Antai-Otong D
    Perspect Psychiatr Care; 2008 Apr; 44(2):120-3. PubMed ID: 18366366
    [No Abstract]   [Full Text] [Related]  

  • 14. Drugs for Alzheimer's disease and related dementias.
    Gauthier S
    BMJ; 2005 Apr; 330(7496):857-8. PubMed ID: 15831849
    [No Abstract]   [Full Text] [Related]  

  • 15. Quetiapine for sleep.
    Yost S; White J
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):53-5. PubMed ID: 20345201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mental disorders in the elderly.
    Stern LZ; Bernick C
    Compr Ther; 1987 May; 13(5):43-50. PubMed ID: 2884074
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy of neuropsychiatric symptoms: opportunities, challenges and current prospects.
    Rabins PV; Lyketsos CG
    Nat Clin Pract Neurol; 2007 May; 3(5):239. PubMed ID: 17479071
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Neuropharmacology patient management series. Alzheimer's disease.
    Sinka E; Forchetti CM
    Clin Neuropharmacol; 1999; 22(6):307-11. PubMed ID: 10626089
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic drugs in dementia: benefits and harm.
    Ballard C; Howard R
    Nat Rev Neurosci; 2006 Jun; 7(6):492-500. PubMed ID: 16715057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.